NextGxDx Inc.
Empowering physicians to efficiently identify the right genetic tests for their patients.
Empowering physicians to efficiently identify the right genetic tests for their patients.
Concert Genetics is a biotechnology and health care startup founded in 2010. The company's mission revolves around empowering physicians to efficiently identify the right genetic tests for their patients. Their recent Venture Round investment at 08 January 2018 was backed by Deerfield. This investment serves as a testament to the potential and promise of Concert Genetics in leveraging genetics for improved healthcare outcomes. As technology continues to play an increasingly pivotal role in healthcare, Concert Genetics stands at the forefront, poised to make a significant impact in the biotechnology and health care industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | Unknown | 1 | Deerfield | 08 Jan 2018 |
| Venture Round | $1.47M | 1 | Sovereign’s Capital | 06 Sep 2016 |
| Venture Round | $1.50M | - | 02 Oct 2015 | |
| Venture Round | $2.23M | - | 14 Oct 2014 | |
| Series B | $2.95M | 3 |
|
05 Mar 2014 |
No recent news or press coverage available for NextGxDx Inc..
We care about your data, and we'd love to use cookies make your experience better.
